Asana BioSciences LLC

Asana BioSciences LLC

Asana BioSciences LLC

Overview
Date Founded

2014

Headquarters

Princeton Pike Corporate Center,1009 Lenox Drive,Suite 106,Lawrenceville, NJ 08648

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Asana BioSciences LLC, part of Amneal Pharmaceuticals, Inc., is a company headquartered in Lawrenceville, NJ. The firm operates as a clinical-stage biopharmaceutical company. It was founded by Chintu Patel.The company says this about itself: Asana BioSciences is a clinical stage biopharmaceutical company based in Lawrenceville, NJ. Asana is focused on discovery and development of novel targeted investigational medicines in immunology/inflammation and oncology. Additional oncology pipeline candidates in Asana’s portfolio include: ASN003 is a dual-selective inhibitor of BRAF and PI3 kinases. Dual targeting of RAF and PI3K pathways has the potential to overcome and/or delay acquired resistance to selective RAF inhibitors. ASN003 is in Phase 1 development in patients with BRAFV600 mutated metastatic melanoma, metastatic colorectal and advanced non-small cell lung cancer (NCT02961283). ASN004 is an antibody drug conjugate that targets the 5T4 oncofetal antigen, which is expressed in a wide range of malignant tumors but has very limited expression in normal tissues. ASN004 demonstrates robust and durable antitumor activity after single administration in multiple human tumor xenograft models. A First-in-Human Phase 1 trial is being planned.

Website

http://www.asanabiosciences.com

In The News
Business Wire
October 22, 2020
Asana BioSciences to Present Clinical Data on Oral ASN007, A Novel ERK1/2 Inhibitor, at the 32nd EORTC-NCI-AACR Symposium
Business Wire
October 20, 2020
Asana BioSciences to Present Positive Results from Phase 2b Study of Oral JAK/SYK Inhibitor Gusacitinib in Patients with Chronic Hand Eczema in the Late-Breaking News Session at the EADV Virtual Congress
Business Wire
June 2, 2020
Asana BioSciences Announces Positive Topline Results from Phase 2b Study of Oral JAK/SYK Inhibitor Gusacitinib (ASN002) in Patients with Chronic Hand Eczema: Rapid and Significant Improvement Demonstrated
Business Wire
March 10, 2020
Asana BioSciences Announces Topical Sodium Channel Blocker ASN008 Achieves Positive Results for the Treatment of Pruritus in Atopic Dermatitis; and Provides Update on JAK/SYK Inhibitor Gusacitinib in Phase 2 Studies for Chronic Hand Eczema and AD
Business Wire
October 24, 2019
Asana BioSciences to Present Phase 1 Clinical Safety and Efficacy Data of Oral, Once-Weekly, ASN007, a Novel ERK 1/2 Inhibitor, at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Sandeep Gupta

Founder

Pablo Jimenez

Vice President & Therapeutic Area Head of Immunology

Shashank Mahashabde

Vice President-Chemistry, Manufacturing & Controls

Board of Directors
Gautam Patel

Managing Director at Tarsadia Investments LLC

Trending People
European Central Bank
GRAPHIC-Let's talk about bonds: Five questions for the ECB - Nasdaq
Champions League, Inc.
Speeding Toward Title, City Hits a Pothole - The New York Times
Manchester United Limited
United condemn City's streak to a sour ending - The Independent UK
Manchester United Football Club Ltd.
Transfer rumours: Salah, Brownhill, Gerrard, Christensen, McCormick, Hamsik - BBC
Instagram LLC
Explainer More than you need to know about Harry and Meghan’s Oprah interview, a... - The Salt Lake Tribune
Trending Organizations
European Central Bank
GRAPHIC-Let's talk about bonds: Five questions for the ECB - Nasdaq
Champions League, Inc.
Speeding Toward Title, City Hits a Pothole - The New York Times
Manchester United Limited
United condemn City's streak to a sour ending - The Independent UK
Manchester United Football Club Ltd.
Transfer rumours: Salah, Brownhill, Gerrard, Christensen, McCormick, Hamsik - BBC
Instagram LLC
Explainer More than you need to know about Harry and Meghan’s Oprah interview, a... - The Salt Lake Tribune
Paths to Asana BioSciences LLC
Potential Connections via
Relationship Science
You
Asana BioSciences LLC

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Asana BioSciences LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Asana BioSciences LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Asana BioSciences LLC.